IATA

Integrated Approaches to Testing and Assessment (IATA) 


Description

Welcome to the NURA course on Integrated Approaches to Testing and Assessment (IATA).


This course includes presenters from diverse backgrounds to discuss the use of IATAs for regulatory testing, including various regulatory industry representatives and method developers and users. 


Speakers:

Kristie Sullivan, MPH, (formerly) Physicians Committee for Responsible Medicine, Moderator

Hans Raabe, Institute for In Vitro Sciences

Nicole Kleinstreuer, PhD, NICEATM

Richard Judson, PhD, US EPA

Priyanka Sura, DVM, MS (Epi.), MS (Tox.), DABT, ANGUS Chemical Company

Gavin Maxwell, PhD, Unilever

Clive Roper, PhD, (formerly) In Vitro Sciences Charles River Edinburgh, Ltd.

Tomaž Mohorič, PhD, Edelweiss Connect

Joshua Schmidt, PhD SenzaGen Inc.

Jessica Palmer, MSc, Stemina Biomarker Discovery

Ruchir Shah, PhD, Sciome

Salil Pendse, MSc, Scitovation

Rebecca Clewell, PhD, 21st Century Tox Consulting

Pam Spencer, PhD, ANGUS Chemical Company

Helena Hogberg, PhD, Johns Hopkins University

Terry Schultz, PhD, University of Tennessee

Esther Haugabrooks, PhD (formerly) Physicians Committee on Responsible Medicine


This course was recorded in December 2019. Credentials and affiliations for speakers and presenters may have changed since the recording.


The videos in this course are available with English and Spanish subtitles. To access these, select the "Settings" (gear) icon within the video.

Content
  • Introduction to the Integrated Approaches to Testing and Assessment Course
  • Introduction to Testing Strategies, IATAs, and DAs: Making Sense of the Science
  • International Activities on Integrated Approaches to Testing & Assessment (IATA)
  • Using New Approach Methods to Assess Estrogen and Androgen Receptor Activity
  • Strategies and Applications of NAMs to Address REACH Data Gaps: AMP™ Case Study 
  • Panel Discussion, Day 1
  • NAMs Skin Absorption Quantitative Risk Assessment and Respiratory Toxicology
  • SaferSkin™: Skin Safety Assessment Using New Approach Methodologies
  • The GARD Assay, Integrated Approaches, and Beyond
  • devTOX quickPredict: Developmental Toxicity Testing using NAMs
  • Rapid Evidence Mapping for Health: A Case Study
  • Using In Vitro Assays, MoAViz and PLETHEM to Establish In Vivo POD
  • Using Comp Tools for Rapid Estimation of MoE to Support Decision Making
  • Panel Discussion, Day 2
  • Speaker-Led Discussion: NAMs to Reduce Uncertainties in Human RA
  • An Alternative Approach to Improve the Assessment of Developmental Neurotoxicity
  • Population Life Course Exposure to Health Effects Model - PLETHEM
  • Rapid Risk Assessment Tools and Use
  • How to Build a Category-Based Read-Across
  • Integration of NAMs for the Future of Regulatory Applications
  • Course Survey, IATA
Completion rules
  • All units must be completed
  • Leads to a certificate with a duration: Forever